Department of Health and Social Care written question – answered at on 7 December 2018.
Ben Bradshaw
Labour, Exeter
To ask the Secretary of State for Health and Social Care, what other aspects of medicines regulation including regulation related to patient safety is postponed due to contingency planning for the UK leaving the EU without a deal; and if he will make a statement.
Jackie Doyle-Price
The Parliamentary Under-Secretary for Health and Social Care
The Government is committed to making sure that patients continue to access safe and innovative medicines and devices, and regulation related to medicines and patient safety have therefore not been postponed because of contingency planning.
For example, we have continued with the implementation of the Falsified Medicines Directive, which is designed to help identify and remove falsified medicines from the supply chain, ahead of coming into force in February 2019, and continued to make the necessary preparations to implement the new Clinical Trials Regulation and Medical Devices Regulation, both due to be implemented before the end of 2020.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Secretary of State was originally the title given to the two officials who conducted the Royal Correspondence under Elizabeth I. Now it is the title held by some of the more important Government Ministers, for example the Secretary of State for Foreign Affairs.
